Emmyon, Inc.

  • About Us
    • Overview
    • People
  • Technology
    • Platform
    • Natural Compounds
    • Novel Compounds
    • Patents
    • Publications
  • Commercial Applications
    • Human Nutrition
    • Companion Animal Nutrition
    • Production Animal Nutrition
    • Pharmaceuticals
  • News
  • Contact
Home / News / Emmyon scientists discover new molecular mechanisms of skeletal muscle atrophy

Emmyon scientists discover new molecular mechanisms of skeletal muscle atrophy

Apr 8, 2015 By redilson

January 15, 2015, Iowa City, IA. – Emmyon scientists Chris Adams and Scott Ebert have co-authored two new papers describing novel molecular mechanisms of skeletal muscle atrophy. The research was performed in the Adams laboratory at the University of Iowa.

The first paper identifies two proteins (p53 and ATF4) that work together to cause muscle atrophy when muscles are immobilized (American Journal of Physiology – Endocrinology and Metabolism, volume 307, pages E245-261).

The second paper identifies a protein (spermine oxidase) that helps to protect muscle from atrophy (American Journal of Physiology – Endocrinology and Metabolism, volume 308, pages E144-158).

Understanding basic mechanisms of skeletal muscle atrophy helps us find new ways to combat it.

Filed Under: News

Emmyon logo
emmyon@emmyon.com LinkedIn logo
Emmyon® is a registed trademark of Emmyon, Inc.
© Copyright 2018 - 2026 Emmyon, Inc. All Rights Reserved.